The ILSE Seed Fund is intended to address the development gap between early stage research and attractive, investment- and venture-grade opportunities and to help alleviate the decline in funding for very early-stage NJ Life Science ventures. The fund is meant to support proof-of-concept work, data collection, and/or prototyping that can yield important information or further development that would make a technology more commercially attractive. The ILSE Seed Fund will provide pre-seed funding to very early stage companies in the New Jersey life science cluster. The goal of the Fund is to leverage the extensive, world class biomedical research at New Jersey’s universities. Preference will be given participants in the ILSE Accelerator.